Coronavirus

The 2019 coronavirus (COVID-19) pandemic, caused by the SARS-CoV-2 novel virus, originated in Wuhan, China before rapidly spreading around the world.


COVID-19 is a highly infectious respiratory disease, with a high rate of transmissibility. Symptoms of infection include fever, joint and muscle aches, respiratory distress, loss of the sense of taste, cognitive fog, fatigue, sore throat, and more. Senior citizens are most at risk of dying from the disease, though secondary pre-existing conditions like obesity can make some patients more susceptible to danger. In severe cases, patients undergo respiratory distress and require intubation on ventilators. 


In response to the coronavirus pandemic, governments have initiated several policies to prevent spread. Many countries have severely restricted flights or entry into their state, with some like Israel adopting color systems to rank the risk posed by each destination. Contact tracing has become the norm, with citizens being obligated to quarantine after they have come into contact with an infected person. Social distancing and mask mandates have also become popular in many countries to prevent spread of infection. Early in the pandemic, lockdowns were used to prevent interaction between the public, in a severe attempt to halt transmission. Perhaps most controversial were the introduction of coronavirus passports, which would allow vaccinated citizens to move freely with a new form of ID. Critics assert that coronavirus passports represent an extreme violation of liberties.


There is an ongoing debate as to the origin of the coronavirus. Initially, it was accepted that the coronavirus originated in a wet market in Wuhan, China, within bats sold as food. However, it has been suggested that the virus may have originated from a virus research lab in Wuhan.


Several pharmaceutical companies have developed innovative mRNA vaccines to counter the coronavirus. Pfizer, Biontech, Astrazeneca, Moderna, Sinopharm and others have produced vaccines, however there is ongoing debate about their efficacy against new strains of the virus. Other pharmaceutical companies have developed treatments and drugs to alleviate and combat coronavirus symptoms.


The coronavirus is prone to mutations, and has already produced several well known variants, including the Delta and Lambda strains. The pandemic and virus may also colloquially be known as corona and COVID.

Read More
Less

Israel's Mizrahi Tefahot Bank Q2 profit tops expectations

In the April-June period, the bank said it earned 1.05 billion shekels ($325 million), up from 988 million a year earlier.

By REUTERS
15/08/2022

COVID-19: Pfizer CEO Albert Bourla tests positive, experiencing mild symptoms

Pfizer CEO Albert Bourla has started the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions.

By REUTERS
15/08/2022

Partisanship influences how people view pandemic response - report

A Pew Research Center survey found that people's views of their government's handling of the COVID-19 pandemic are heavily influenced by partisanship.

COVID-19 mRNA vaccines safe to use during pregnancy, study finds

Four percent more unvaccinated pregnant women had health complications than pregnant women who received the mRNA vaccine against COVID-19 after a week in a new study.

CDC no longer recommends students quarantine for COVID-19 exposures in US

The US CDC no longer recommends quarantine for students exposed to COVID-19.

By REUTERS
11/08/2022

Trip to UK shows how much COVID-19 has changed London

It was as if COVID-19, Brexit and the invasion of Ukraine had caused a huge sink-hole through which many things were beginning to disappear

By ROBERT HERSOWITZ
11/08/2022

This antibody may protect against COVID-19 and all its variants - study

The antibody in question was easily induced in rhesus macaque monkeys and provided broad protection against not just COVID-19 and variants but other SARS viruses.

10/08/2022
Coronavirus vaccine under development (illustrative)

Pfizer or Sinovac: Which COVID-19 vaccine booster is best? - study

A study on nearly 14 million people in Malaysia who were vaccinated with Pfizer, Sinovac or a combination of the two seems to indicate that Pfizer offers stronger protection.

10/08/2022
A resident wearing a face mask dances at a blocked residential area after the lockdown was lifted in

China puts tourist island on lockdown leaving dozens stranded

China locked down an island due to the rise of COVID-19 cases leaving many tourists stuck inside hotels.

By REUTERS
07/08/2022

One in eight COVID-19 patients develop long-COVID symptoms - study

A Netherlands-based study has found that 12.7% of COVID-positive people in the general population will experience symptoms of long COVID, translating to one in eight COVID patients.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy